Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05787743
Other study ID # MA-T3-T1
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 17, 2023
Est. completion date November 16, 2023

Study information

Verified date November 2023
Source Universiti Sains Malaysia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A single-center, double-blind, randomised, placebo-controlled parallel-group study. Selected subjects will be randomised into active and control groups in a ratio of 1:1. Investigational products assigned will be applied on the facial skin as part of daily skin care routine. The effects will be observed during the 24-weeks of use.


Recruitment information / eligibility

Status Terminated
Enrollment 41
Est. completion date November 16, 2023
Est. primary completion date November 16, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 25 Years to 45 Years
Eligibility Inclusion Criteria: 1. Healthy female individuals, aged 25 - 45 years old, inclusive 2. Fitzpatrick skin type II to IV 3. In generally good health and skin condition as determined by the PI or designee, based on medical history reported by the subject. 4. Willing to provide informed consent and comply with study procedures Exclusion Criteria: 1. Has a history of chronic drug or alcohol abuse 2. Is current smoker 3. History of severe allergic reactions to topical products or vitamin E 4. Participant with severe and uncontrolled comorbidities (including but not limited to e.g. diabetes, hypertension, kidney failure) 5. Pregnant, breastfeeding, or planning pregnancy 6. Participant with known skin conditions (including but not limited to e.g. sensitive skin, eczema and diseased skin e.g. contact dermatitis), uncontrolled medical conditions, or any other condition that could interfere with the study evaluations or increase risk to the participant 7. Participant with compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk 8. Participation in another study within 4 weeks of screening visit

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Facial cream with 2% palm tocotrienols extract
Apply on the face twice a day
Base cream
Apply on the face twice a day

Locations

Country Name City State
Malaysia School of Pharmaceutical Sciences, Universiti Sains Malaysia Pulau Pinang

Sponsors (3)

Lead Sponsor Collaborator
Universiti Sains Malaysia Avantsar Sdn. Bhd., Malaysia Palm Oil Board

Country where clinical trial is conducted

Malaysia, 

References & Publications (25)

Choi B, Heo JH, Kwon HJ, Lee ES, Sohn S. Tocotrienols enhance melanosome degradation through endosome docking/fusion proteins in B16F10 melanoma cells. Food Funct. 2013 Oct;4(10):1481-8. doi: 10.1039/c3fo60289c. — View Citation

Chu CC, Hasan ZABA, Tan CP, Nyam KL. In Vitro Antiaging Evaluation of Sunscreen Formulated from Nanostructured Lipid Carrier and Tocotrienol-Rich Fraction. J Pharm Sci. 2021 Dec;110(12):3929-3936. doi: 10.1016/j.xphs.2021.08.020. Epub 2021 Aug 21. — View Citation

Draize, J.H., Woodard, G., Calvery, H.O., 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmacology and Experimental Therapeutics 82, 377-390.

Harun MS, Wong TW, Fong CW. Advancing skin delivery of alpha-tocopherol and gamma-tocotrienol for dermatitis treatment via nanotechnology and microwave technology. Int J Pharm. 2021 Jan 25;593:120099. doi: 10.1016/j.ijpharm.2020.120099. Epub 2020 Nov 28. — View Citation

Ikeda S, Niwa T, Yamashita K. Selective uptake of dietary tocotrienols into rat skin. J Nutr Sci Vitaminol (Tokyo). 2000 Jun;46(3):141-3. doi: 10.3177/jnsv.46.141. — View Citation

Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstr Surg. 2001 Nov;108(6):1735-50; discussion 1751-2. doi: 10.1097/00006534-200111000-00048. — View Citation

Makpol S, Abidin AZ, Sairin K, Mazlan M, Top GM, Ngah WZ. gamma-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals. Oxid Med Cell Longev. 2010 Jan-Feb;3(1):35-43. doi: 10.4161/oxim.3.1.9940. — View Citation

Mei Yee, C., Ahmad, N., Azizul Hasan, Z.A., Abu Hasan, H., 2014. Tocotrienol-Based Facial Masks, MPOB Information Series. Malaysian Palm Oil Board, Kuala Lumpur, Malaysia.

Muggli R. Systemic evening primrose oil improves the biophysical skin parameters of healthy adults. Int J Cosmet Sci. 2005 Aug;27(4):243-9. doi: 10.1111/j.1467-2494.2005.00274.x. — View Citation

Musalmah M, Nizrana MY, Fairuz AH, NoorAini AH, Azian AL, Gapor MT, Wan Ngah WZ. Comparative effects of palm vitamin E and alpha-tocopherol on healing and wound tissue antioxidant enzyme levels in diabetic rats. Lipids. 2005 Jun;40(6):575-80. doi: 10.1007/s11745-005-1418-9. — View Citation

Patel V, Rink C, Gordillo GM, Khanna S, Gnyawali U, Roy S, Shneker B, Ganesh K, Phillips G, More JL, Sarkar A, Kirkpatrick R, Elkhammas EA, Klatte E, Miller M, Firstenberg MS, Chiocca EA, Nesaretnam K, Sen CK. Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. J Nutr. 2012 Mar;142(3):513-9. doi: 10.3945/jn.111.151902. Epub 2012 Feb 1. — View Citation

Pedrelli VF, Lauriola MM, Pigatto PD. Clinical evaluation of photoprotective effect by a topical antioxidants combination (tocopherols and tocotrienols). J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1449-53. doi: 10.1111/j.1468-3083.2011.04219.x. Epub 2011 Sep 14. — View Citation

Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med. 2007 Oct-Dec;28(5-6):692-728. doi: 10.1016/j.mam.2007.03.001. Epub 2007 Mar 27. — View Citation

Shibata A, Nakagawa K, Kawakami Y, Tsuzuki T, Miyazawa T. Suppression of gamma-tocotrienol on UVB induced inflammation in HaCaT keratinocytes and HR-1 hairless mice via inflammatory mediators multiple signaling. J Agric Food Chem. 2010 Jun 9;58(11):7013-20. doi: 10.1021/jf100691g. — View Citation

Suzuki YJ, Tsuchiya M, Wassall SR, Choo YM, Govil G, Kagan VE, Packer L. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry. 1993 Oct 12;32(40):10692-9. doi: 10.1021/bi00091a020. — View Citation

Thiele JJ, Traber MG, Podda M, Tsang K, Cross CE, Packer L. Ozone depletes tocopherols and tocotrienols topically applied to murine skin. FEBS Lett. 1997 Jan 20;401(2-3):167-70. doi: 10.1016/s0014-5793(96)01463-9. — View Citation

Thiele JJ, Traber MG, Tsang K, Cross CE, Packer L. In vivo exposure to ozone depletes vitamins C and E and induces lipid peroxidation in epidermal layers of murine skin. Free Radic Biol Med. 1997;23(3):385-91. doi: 10.1016/s0891-5849(96)00617-x. — View Citation

Traber MG, Podda M, Weber C, Thiele J, Rallis M, Packer L. Diet-derived and topically applied tocotrienols accumulate in skin and protect the tissue against ultraviolet light-induced oxidative stress. Asia Pac J Clin Nutr. 1997 Mar;6(1):63-7. — View Citation

Tsuduki T, Kuriyama K, Nakagawa K, Miyazawa T. Tocotrienol (unsaturated vitamin E) suppresses degranulation of mast cells and reduces allergic dermatitis in mice. J Oleo Sci. 2013;62(10):825-34. doi: 10.5650/jos.62.825. — View Citation

Yamada Y, Obayashi M, Ishikawa T, Kiso Y, Ono Y, Yamashita K. Dietary tocotrienol reduces UVB-induced skin damage and sesamin enhances tocotrienol effects in hairless mice. J Nutr Sci Vitaminol (Tokyo). 2008 Apr;54(2):117-23. doi: 10.3177/jnsv.54.117. — View Citation

Yamashita, E., 2006. Cosmetic benefit of dietary supplements including astaxanthin and tocotrienol on human skin.

Yap WN, Zaiden N, Xu CH, Chen A, Ong S, Teo V, Yap YL. Gamma- and delta-tocotrienols inhibit skin melanin synthesis by suppressing constitutive and UV-induced tyrosinase activation. Pigment Cell Melanoma Res. 2010 Oct;23(5):688-92. doi: 10.1111/j.1755-148X.2010.00740.x. Epub 2010 Jul 27. No abstract available. — View Citation

Yap WN. Tocotrienol-rich fraction attenuates UV-induced inflammaging: A bench to bedside study. J Cosmet Dermatol. 2018 Jun;17(3):555-565. doi: 10.1111/jocd.12421. Epub 2017 Sep 26. — View Citation

Yusuf, N.Z., Azizul Hasan, Z.A., Ismail, R., 2011. TOCOGELS As Anti-Inflammatory Agents, MPOB Information Series. Malaysian Palm Oil Board, Kuala Lumpur, Malaysia.

Zainal Z, Khaza'ai H, Kutty Radhakrishnan A, Chang SK. Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studies. Food Res Int. 2022 Jun;156:111175. doi: 10.1016/j.foodres.2022.111175. Epub 2022 Mar 21. — View Citation

* Note: There are 25 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Percent change from baseline in wrinkle (SEw) Wrinkle 24 week
Secondary Percent change from baseline in roughness (SEr), scaliness(SEsc), smoothness (SEsm), TEWL, Young's modulus, viscoelasticity, retraction time, collagen content, skin thickness, pigmentation index, erythema index, skin colour, pH, sebum and hydration Skin biophysical properties 24 week
Secondary Percent change from baseline for Lemperle Wrinkle Assessment Scale Wrinkle (scale 1 - 5; higher score for more wrinkles) 24 week
Secondary Percent change from baseline in scores of survey (BeautyQoL) Survey (score 0 - 100%) 24 week
See also
  Status Clinical Trial Phase
Completed NCT05098912 - Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction N/A
Completed NCT05271136 - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum N/A
Completed NCT05096247 - Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device N/A
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT04128046 - The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation N/A
Active, not recruiting NCT04727099 - Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™ N/A
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Not yet recruiting NCT05524779 - BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement N/A
Completed NCT05514782 - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum N/A
Completed NCT06123572 - A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel N/A
Completed NCT04911374 - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream N/A
Recruiting NCT04989361 - Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles. N/A
Recruiting NCT04540900 - A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions Phase 1
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Active, not recruiting NCT06219278 - A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles N/A
Active, not recruiting NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System N/A
Completed NCT04650620 - Study to Evaluate the Performance and Safety of the Medical Device Plenhyage® N/A
Completed NCT03729700 - The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome N/A